Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01277159 · ClinicalTrials.gov registry record · NA
Duration of Analgesia After Popliteal Fossa Nerve Blockade: Effects of Dexamethasone and Buprenorphine
A NA study, sponsored by Hospital for Special Surgery, New York.
- Completed
- Registry status
- NA
- Development phase
- 108
- Enrollment target
NCT01277159: Completed NA study, sponsored by Hospital for Special Surgery, New York.
NCT01277159 is a NA study that has completed, run by Hospital for Special Surgery, New York. The registered enrollment target is 108 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (92% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01277159, a NA study, has completed, sponsored by Hospital for Special Surgery, New York.
- COMPLETED
- Registry status
- NA
- Development phase
- 108 participants
- Enrollment target
Study Summary
Patients scheduled to go home after ankle surgery at HSS typically receive a sciatic nerve block in the popliteal fossa and oral analgesic tablets (such as Percocet). Popliteal fossa nerve blockade has reduced pain for these patients (YaDeau et al, Anesth Analg 2008;106:1916-20), but unfortunately the patients still often experience moderate to severe pain after the block wears off. The investigators wish to study two additives that may prolong the period of analgesia provided by the nerve block. The additives will be studied in the context of a standardized postoperative multimodal analgesic pathway. Primary outcome: Does adding dexamethasone and / or buprenorphine prolong the analgesia provided by a popliteal fossa nerve block?
Primary Outcome
Does adding dexamethasone and / or buprenorphine prolong the analgesia provided by a popliteal fossa nerve block?
Interventions
- DRUG A. Control Nerve Block. IV Dexamethasone (4 mg).
- DRUG B. Nerve Block with Dexamethasone (4 mg). IV saline.
- DRUG C. Control Nerve Block. IV Dexamethasone (4 mg). IV Buprenorphine (0.3 mg)
- DRUG D. Nerve Block with Buprenorphine (0.3 mg). IV Dexamethasone (4 mg).
- DRUG E. Nerve Block with Dexamethasone (4 mg) / block Buprenorphine (0.3 mg).
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 108 participants |
| Start Date | 2010-10 |
| Est. Completion | 2011-12 |
| Phase | NA |
What the finished NCT01277159 record still lists
NCT01277159 is an interventional study that assigns participants to a tested intervention. The registered 108 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (92% lower).
The record links to 0 conditions, and to 5 interventions - of which A. Control Nerve Block. IV Dexamethasone (4 mg). is the first listed.
NCT01277159 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01277159 about?
NCT01277159 is a clinical study titled "Duration of Analgesia After Popliteal Fossa Nerve Blockade: Effects of Dexamethasone and Buprenorphine". Patients scheduled to go home after ankle surgery at HSS typically receive a sciatic nerve block in the popliteal fossa and oral analgesic tablets (such as Percocet). Popliteal fossa nerve blockade has reduced pain for these patients (YaDeau et al, Anesth Analg 2008;106:1916-20), but unfortunately t...
What is the current status of trial NCT01277159?
This trial is currently completed. It is a NA study. The enrollment target is 108 participants. The study started on 2010-10. Estimated completion is 2011-12.
What interventions are being tested in trial NCT01277159?
The interventions under investigation include: A. Control Nerve Block. IV Dexamethasone (4 mg). (DRUG), B. Nerve Block with Dexamethasone (4 mg). IV saline. (DRUG), C. Control Nerve Block. IV Dexamethasone (4 mg). IV Buprenorphine (0.3 mg) (DRUG), D. Nerve Block with Buprenorphine (0.3 mg). IV Dexamethasone (4 mg). (DRUG), E. Nerve Block with Dexamethasone (4 mg) / block Buprenorphine (0.3 mg). (DRUG).
Who is sponsoring clinical trial NCT01277159?
This trial is sponsored by Hospital for Special Surgery, New York, which has 194 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01277159's enrollment target sits among peer trials
108 825th of 2000 higher than 1,171 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02703207 · 108 participants · NA
Neurocognitive and Health Impact of Sleep Apnea in Elderly Veterans With Comorbid COPD
- NCT02744677 · 108 participants · NA
COMPASSION S3 - Evaluation of the SAPIEN 3 Transcatheter Heart Valve in Patients With Pulmonary Valve Dysfunction
- NCT02781883 · 108 participants · Phase 2
Clinical Trial of BP1001 in Combination With With Venetoclax Plus Decitabine in AML
- NCT03848663 · 108 participants · NA
Visual Remapping to Aid Reading With Field Loss
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia